BioTie Therapies Corp.: Selincro Enters the Market in Italy
9/26/2013 9:32:47 AM
Biotie today announced that its partner H.Lundbeck A/S (Lundbeck) has brought Selincro on the market in Italy. According to the terms of the license agreement between Biotie and Lundbeck for Selincro, Biotie is eligible for a milestone payment of EUR 2 million related to the market entry. Lundbeck will continue the rollout of Selincro in additional European markets through 2013 and into 2014.
Help employers find you! Check out all the jobs and post your resume.